Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

SNTI Senti Biosciences Inc

4,12

-0,05 (-1,20%)

Vor Marktöffnung

Zuletzt aktualisiert: 14:00:37

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

Senti Biosciences (NASDAQ:SNTI)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Senti Biosciences Charts.

Senti Biosciences (NASDAQ:SNTI)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Senti Biosciences Charts.

News Senti Biosciences Inc

Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration with Celest Therapeutics
Montag 16 Dezember 2024 (1 Woche vor) • GlobeNewswire Inc.

Senti Biosciences Announces New Employment Inducement Grants
Mittwoch 4 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Senti Biosciences, Inc. Announces Oversubscribed $37.6 Million Private Placement Equity Financing
Montag 2 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Senti Bio Announces Positive Initial Clinical Data in Phase 1 Clinical Trial of SENTI-202, a Logic Gated, Selective CD33/FLT3-Targeting CAR-NK Cell Therapy for the Treatment of Relapsed/Refractory Hematologic Malignancies Including AML
Montag 2 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Senti Bio Appoints Fran Schulz to Board of Directors
Montag 2 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights
Donnerstag 14 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Senti Bio to Participate in Upcoming Investor Conferences
Dienstag 3 September 2024 (4 Monate vor) • GlobeNewswire Inc.

Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights
Dienstag 13 August 2024 (4 Monate vor) • GlobeNewswire Inc.

Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202
Montag 5 August 2024 (5 Monate vor) • GlobeNewswire Inc.

Senti Bio Announces Reverse Stock Split
Dienstag 16 Juli 2024 (5 Monate vor) • GlobeNewswire Inc.

Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
Montag 1 Juli 2024 (6 Monate vor) • GlobeNewswire Inc.

Form ARS - Annual Report to Security Holders
Mittwoch 29 Mai 2024 (7 Monate vor) • Edgar (US Regulatory)

Weitere Senti Biosciences Inc News-Artikel

B Riley Principal Merger

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen